BETAWICK 16 (Tablet)

BETAWICK 16 is a high-potency tablet formulation containing Betahistine Dihydrochloride 16 mg.

Composition: Betahistine Dihydrochloride 8 mg / 16 mg
Dosage Form: Tablet

Clinical Pharmacology

Betahistine has histamine H1 agonist and H3 antagonist activity and is thought to influence inner-ear microcirculation and vestibular function.

Indications & Usage

May be used for symptomatic management of:

• Ménière’s disease
• Recurrent vertigo associated with vestibular disorders
• Vestibular dizziness
• Associated tinnitus and aural fullness where clinically appropriate

Contraindications

• Pheochromocytoma
• Hypersensitivity

Warnings & Precautions

Use cautiously in patients with bronchial asthma and history of peptic ulcer disease.

Drug Interactions

Antihistamines may theoretically reduce the effect of betahistine. MAO inhibitors may alter exposure.

Pregnancy & Lactation

Use only when clearly indicated.

Dosage & Administration

Dosage should be individualized. The 8 mg and 16 mg strengths should be used according to the prescribed regimen.

Adverse Reactions

Nausea, dyspepsia, headache and abdominal discomfort.

Therapeutic Focus: Vertigo Management | Primary Specialty: ENT